Search clinical trials for: FluMist

Total 88 results

MedImmune LLC
AstraZeneca

Completed

Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age (FluMist)

Healthy | Influenza

United States
MedImmune LLC

Completed

A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age (MI-CP185)

Healthy or Stable Underlying Chronic Medical Condition

United States
MedImmune LLC

Completed

Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age

Influenza

United States
MedImmune LLC

Completed

A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children (LAIV)

Healthy or Stable Chronic Illness

United States
MedImmune LLC

Completed

Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Proteomic Profiling for Influenza Vaccination - FluMist

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Withdrawn

Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood (FLU-Tonsil)

Influenza

United States
University of North Carolina, Chapel Hill
MedImmune LLC; University of North Carolina

Completed

Home Administration of FluMist by Parents/Caregivers

Influenza

United States
MedImmune LLC

Completed

A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults

Healthy

United States
MedImmune LLC

Completed

Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program

Influenza

United States
MedImmune LLC

Completed

Study To Evaluate the Safety of Bivalent Vaccine

Healthy

United States
MedImmune LLC

Completed

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Healthy | Influenza

United States
University of Bergen
Haukeland University Hospital

Active, not recruiting

Immune Response To Intranasal Influenza Vaccination

Tonsillitis, Hypertrophy

Norway
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)

Influenza
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Completed

Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers

Smoking | Respiratory Tract Infections | Influenza, Human | Habits

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist

Influenza

United States
University of North Carolina, Chapel Hill
National Institute of Environmental Health Sciences (NIEHS); Environmental...

Completed

Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies (FLAIR)

Allergic Rhinitis

United States
Chronic Obstructive Pulmonary Disease Trial Network...
The Novo Nordic Foundation

Not yet recruiting

Vaccine Pandemic Preparedness Through Airway Immunology Characterization (VAXXAIR)

Influenza, Human

United Kingdom, Denmark
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)

Influenza
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Immunity Against Pandemic Respiratory Virus

Influenza

United States
MedImmune LLC

Completed

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Influenza

United States
MedImmune LLC

Completed

A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age (MI-CP206)

Healthy or Stable Underlying Chronic Medical Condition

United States
Marshfield Clinic Research Foundation
University of Wisconsin, Madison; Centers for Disease Control and Prevention

Completed

Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents

Influenza A Virus Infection | Influenza B Virus Infection | Immune Response to Influenza Vaccine

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)

Influenza

United States
St. Jude Children's Research Hospital

Completed

A Study of a Live Intranasal Influenza Vaccine in Children With Cancer (FMRESP)

Cancer

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children (FluMist)

Healthy

Finland, Belgium
International Maternal Pediatric Adolescent AIDS...
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

Influenza | HIV-1 Infection | Flu | H1N1

United States, Puerto Rico
University of Michigan
Sanofi Pasteur, a Sanofi Company

Completed

Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4 (FLUVACS)

Influenza

United States
MedImmune LLC

Completed

A Post Marking Study to Evaluate the Safety of FluMist in Children

Healthy

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)

Influenza

United States
MedImmune LLC

Completed

Safety Study to Evaluate FluMist in Immunocompromised Children

Cancer

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)

Influenza
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Human Mucosal Immune Responses to Influenza Virus (SLVP026)

Influenza
MedImmune LLC

Completed

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children

Influenza
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
National Center for Occupational Health and Infection...
US Department of Veterans Affairs

Terminated

Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Influenza

United States
MedImmune LLC

Completed

A Clinical Study to Assess the Safety of a New Influenza Vaccine

Healthy

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age (SLVP016)

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection (SLVP030)

Healthy | Influenza

United States
Emily McDonald
Canadian Institutes of Health Research (CIHR); Université de Montréal

Completed

Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections (WE SENSE)

Influenza | Viral Respiratory Tract Infection

Canada
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Genetic and Environmental Factors in the Response to Influenza Vaccination (SLVP028)

Healthy | Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009

Influenza

United States
McGill University Health Centre/Research Institute...
Canadian Cystic Fibrosis Foundation; PHAC/CIHR Influenza Research Network; Ministere...

Unknown

LAIV (Flumist®) Administration in CF Patients

Cystic Fibrosis

Canada
MedImmune LLC
University of Pittsburgh; Passport Health

Completed

Assessing Choice in the Employer Setting (ACES) Study (MA181)

Healthy

United States
University of Colorado, Denver
MedImmune LLC

Completed

Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults (QLAIV)

Human Immunodeficiency Virus (HIV)

United States
Baylor College of Medicine
National Institute of Allergy and Infectious Diseases (NIAID); Novartis; Sanofi... and other collaborators

Completed

Control of Epidemic Influenza Through a School-based Influenza Vaccination Program (CEI)

Influenza

United States
Imperial College London
Public Health England

Completed

Safety of Nasal Influenza Immunisation in Children With Asthma (SNIFFLE-4)

Asthma
Imperial College London
Public Health England

Completed

Efficacy & Safety of Nasal Influenza Immunisation in Children (SNIFFLE-3)

Influenza Vaccines Efficacy and Safety

United Kingdom

Search clinical trials for: FluMist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations